Delayed Prostate Cancer Therapy Arlington VA

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

STE 400
(703) 280-5390
8503 Arlington Blvd
Fairfax, VA
Business
Fairfax Northern Virginia Hematology & Oncolo
Specialties
Oncology

Data Provided by:
Martin Ojong-Ntui
(202) 715-5120
900 23rd St Nw
Washington, DC
Specialty
Radiation Oncology

Data Provided by:
Dr.Henry Fox
(202) 296-2440
2440 M St NW # 801
Washington, DC
Gender
M
Education
Medical School: Stanford Univ Sch Of Med
Year of Graduation: 1978
Speciality
Oncologist
General Information
Accepting New Patients: Yes
RateMD Rating
3.5, out of 5 based on 2, reviews.

Data Provided by:
John Milburn Jessup, MD
(202) 687-5277
PO Box 571467-RM
Washington, DC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: New York Med Coll, Valhalla Ny 10595
Graduation Year: 1972

Data Provided by:
Imad A Tabbara
(202) 741-2222
2150 Pennsylvania Ave Nw
Washington, DC
Specialty
Hematology, Hematology / Oncology

Data Provided by:
Nelson G Kalil, MD
(301) 774-6136
18111 Prince Philip Dr
Olney, MD
Business
Community Hematology Oncology Practicioners
Specialties
Oncology

Data Provided by:
Dr.Bruce Kressel
(202) 293-5382
2141 K St NW # 707
Washington, DC
Gender
M
Education
Medical School: Tufts Univ Sch Of Med
Year of Graduation: 1973
Speciality
Oncologist
General Information
Accepting New Patients: Yes
RateMD Rating
2.9, out of 5 based on 15, reviews.

Data Provided by:
James H Simon, MD
2150 Pennsylvania Ave NW
Washington, DC
Specialties
Oncology (Cancer), Radiation Oncology, General Practice
Gender
Male
Education
Medical School: Univ Of Ia Coll Of Med, Iowa City Ia 52242
Graduation Year: 1992

Data Provided by:
Henry Bennett Fox, MD
(202) 296-2440
2440 M St NW Ste 606
Washington, DC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Stanford Univ Sch Of Med, Stanford Ca 94305
Graduation Year: 1978

Data Provided by:
Neerav Narenza Shukla, MD
Washington, DC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: George Washington Univ Sch Of Med & Hlth Sci, Washington Dc 20037
Graduation Year: 2000

Data Provided by:
Data Provided by:

Delayed Prostate Cancer Therapy

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com